[BIO-K] New Growth Strategy
-The Future of Medicine Created by Technological Innovation-

May 14 [Wed]
10:30-12:30
Course Leader
Ken-ichi Arai
Professor Emeritus, The University of Tokyo /
Director, Chairman, SBI Biotech Co., Ltd.
Sub-course Leader
Toichi Takenaka
Chairman
Japan Health Sciences Foundation /
Former Chairman of the Board,
Astellas Pharma Inc.

Our Challenge for Innovation
-Building Resilience for Sustainable Growth-

Yoshihiko Hatanaka
Representative Director, President & CEO,
Astellas Pharma Inc.



[Abstract]
Astellas is a research-based pharmaceutical company committed to transforming progress in science and technology into value for patients. Innovation is key to our growth, and in this keynote address, I will discuss how we are leveraging our strengths to drive innovation and sustainable growth.


Health Care Policy and New Framework for Promoting Medical Research and Development (in Japan)

Hiroto Izumi
Director-General of the Office of Healthcare Policy,
Special Advisor to the Prime Minister,
Cabinet Secretariat


[Abstract]
This presentation provides an overview of the health care policy and of the new framework for promotion of medical R&D. The Japanese government has established the Headquarters of health care policy in the Cabinet, and will aim to establish an independent administrative institution in charge of practical tasks for integrated research management.


Developing Biotechnology R&D Systems in India
-The Challenges for Growing Bioeconomies-

K. VijayRaghavan
Secretary to the Government of India,
Dept. of Biotechnology,
Ministry of Science & Technology, Government of India


[Abstract]
India faces extraordinary challenges as it moves to lift large numbers of people from poverty. Science in general and biotech in particular can play an important role here. International collaboration is a key component. I will address how, despite many obvious hurdles, India can work with the world to address challenges for our planet’s future.


[Biography]
K. VijayRaghavan is Secretary, Department of Biotechnology Government of India. He was trained as a Chemical Engineer and then a Developmental Biologist. He was formerly the Director of the National Centre for Biological Sciences, Tata Institute of Fundamental Research and inStem, the Institute of Stem Cell Biology and Regenerative Medicine. He is a member of the Board of Governors of the Okinawa Institute of Science and Technology (OIST). VijayRaghavan is a fellow of the Indian Science Academies, the TWAS and the Royal Society.